SYRA HEALTH CORP.
SYRACIK 0001922335
Revenue (TTM)
$7.77M
−9.5% YoY
Q1 May 2026
Net Income (TTM)
−$520.78K
+76.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.05
+84.0% YoY
Q1 May 2026
Gross Margin
36.9%
Q1 May 2026
Operating Margin
-7.4%
Q1 May 2026
Net Margin
-6.7%
Q1 May 2026
Free Cash Flow (TTM)
$674.26K
Q1 May 2026
Cash
$2.92M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
11.34M sh
Q1 May 2026